Immune Checkpoint Inhibitors Pose ACTH Deficiency Risk
Immune checkpoint inhibitors, increasingly used to treat a variety of cancers, can cause unpredictable immune-related adverse events including endocrinopathies.
First Look
source https://www.medscape.com/viewarticle/989856?src=rss
First Look
source https://www.medscape.com/viewarticle/989856?src=rss
Comments
Post a Comment